Furthermore, chebulanin treatment decreased the expression of the autoimmune disease-related cytokines (TNF-α and IL-6) and enzymes (COX-2 and MMP-3), indicating that the therapeutic mechanism of chebulanin may involve inhibition of inflammatory signaling in the joints of CIA mice. Here, IL6 is linked to autoimmune disease.